nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—kidney cancer	0.382	1	CbGaD
Nadolol—ABCB1—Temsirolimus—kidney cancer	0.0907	0.225	CbGbCtD
Nadolol—ABCB1—Pazopanib—kidney cancer	0.0476	0.118	CbGbCtD
Nadolol—ABCB1—Dactinomycin—kidney cancer	0.0436	0.108	CbGbCtD
Nadolol—ABCB1—Gemcitabine—kidney cancer	0.0344	0.0856	CbGbCtD
Nadolol—ABCB1—Erlotinib—kidney cancer	0.034	0.0845	CbGbCtD
Nadolol—ABCB1—Paclitaxel—kidney cancer	0.0311	0.0773	CbGbCtD
Nadolol—ABCB1—Sorafenib—kidney cancer	0.0276	0.0687	CbGbCtD
Nadolol—ABCB1—Vinblastine—kidney cancer	0.0273	0.0678	CbGbCtD
Nadolol—ABCB1—Vincristine—kidney cancer	0.0268	0.0667	CbGbCtD
Nadolol—ABCB1—Sunitinib—kidney cancer	0.0224	0.0557	CbGbCtD
Nadolol—ABCB1—Doxorubicin—kidney cancer	0.0168	0.0417	CbGbCtD
Nadolol—Rash—Temsirolimus—kidney cancer	0.000348	0.00161	CcSEcCtD
Nadolol—Dermatitis—Temsirolimus—kidney cancer	0.000348	0.00161	CcSEcCtD
Nadolol—Decreased appetite—Erlotinib—kidney cancer	0.000345	0.0016	CcSEcCtD
Nadolol—Dizziness—Pazopanib—kidney cancer	0.000344	0.00159	CcSEcCtD
Nadolol—Oedema—Sunitinib—kidney cancer	0.000343	0.00159	CcSEcCtD
Nadolol—Alopecia—Gemcitabine—kidney cancer	0.000342	0.00159	CcSEcCtD
Nadolol—Fatigue—Erlotinib—kidney cancer	0.000342	0.00158	CcSEcCtD
Nadolol—Gastritis—Capecitabine—kidney cancer	0.000341	0.00158	CcSEcCtD
Nadolol—Anorexia—Sorafenib—kidney cancer	0.00034	0.00158	CcSEcCtD
Nadolol—Pain—Erlotinib—kidney cancer	0.000339	0.00157	CcSEcCtD
Nadolol—Constipation—Erlotinib—kidney cancer	0.000339	0.00157	CcSEcCtD
Nadolol—Shock—Sunitinib—kidney cancer	0.000338	0.00156	CcSEcCtD
Nadolol—Abdominal distension—Capecitabine—kidney cancer	0.000335	0.00155	CcSEcCtD
Nadolol—Vomiting—Pazopanib—kidney cancer	0.000331	0.00153	CcSEcCtD
Nadolol—Bradycardia—Paclitaxel—kidney cancer	0.00033	0.00153	CcSEcCtD
Nadolol—Rash—Pazopanib—kidney cancer	0.000328	0.00152	CcSEcCtD
Nadolol—Nausea—Temsirolimus—kidney cancer	0.000328	0.00152	CcSEcCtD
Nadolol—Dermatitis—Pazopanib—kidney cancer	0.000328	0.00152	CcSEcCtD
Nadolol—Bronchospasm—Capecitabine—kidney cancer	0.000327	0.00152	CcSEcCtD
Nadolol—Anorexia—Sunitinib—kidney cancer	0.000327	0.00152	CcSEcCtD
Nadolol—Oedema—Dactinomycin—kidney cancer	0.000325	0.00151	CcSEcCtD
Nadolol—Body temperature increased—Everolimus—kidney cancer	0.000325	0.00151	CcSEcCtD
Nadolol—Fluid retention—Doxorubicin—kidney cancer	0.000325	0.0015	CcSEcCtD
Nadolol—Abdominal discomfort—Capecitabine—kidney cancer	0.000319	0.00148	CcSEcCtD
Nadolol—Dyspnoea—Sorafenib—kidney cancer	0.000318	0.00147	CcSEcCtD
Nadolol—Dry eye—Doxorubicin—kidney cancer	0.000316	0.00146	CcSEcCtD
Nadolol—Dyspepsia—Sorafenib—kidney cancer	0.000314	0.00145	CcSEcCtD
Nadolol—Body temperature increased—Erlotinib—kidney cancer	0.000313	0.00145	CcSEcCtD
Nadolol—Visual impairment—Paclitaxel—kidney cancer	0.000313	0.00145	CcSEcCtD
Nadolol—Insomnia—Sunitinib—kidney cancer	0.00031	0.00144	CcSEcCtD
Nadolol—Decreased appetite—Sorafenib—kidney cancer	0.00031	0.00144	CcSEcCtD
Nadolol—Anorexia—Dactinomycin—kidney cancer	0.00031	0.00144	CcSEcCtD
Nadolol—Nausea—Pazopanib—kidney cancer	0.000309	0.00143	CcSEcCtD
Nadolol—Paraesthesia—Sunitinib—kidney cancer	0.000308	0.00143	CcSEcCtD
Nadolol—Fatigue—Sorafenib—kidney cancer	0.000307	0.00143	CcSEcCtD
Nadolol—Hypertension—Vincristine—kidney cancer	0.000307	0.00142	CcSEcCtD
Nadolol—Dyspnoea—Sunitinib—kidney cancer	0.000306	0.00142	CcSEcCtD
Nadolol—Constipation—Sorafenib—kidney cancer	0.000305	0.00141	CcSEcCtD
Nadolol—Pain—Sorafenib—kidney cancer	0.000305	0.00141	CcSEcCtD
Nadolol—Pulmonary oedema—Doxorubicin—kidney cancer	0.000304	0.00141	CcSEcCtD
Nadolol—Weight increased—Capecitabine—kidney cancer	0.000303	0.0014	CcSEcCtD
Nadolol—Tinnitus—Paclitaxel—kidney cancer	0.000303	0.0014	CcSEcCtD
Nadolol—Dyspepsia—Sunitinib—kidney cancer	0.000302	0.0014	CcSEcCtD
Nadolol—Decreased appetite—Sunitinib—kidney cancer	0.000298	0.00138	CcSEcCtD
Nadolol—Asthenia—Vinblastine—kidney cancer	0.000296	0.00137	CcSEcCtD
Nadolol—Fatigue—Sunitinib—kidney cancer	0.000296	0.00137	CcSEcCtD
Nadolol—Depression—Capecitabine—kidney cancer	0.000296	0.00137	CcSEcCtD
Nadolol—Asthenia—Everolimus—kidney cancer	0.000295	0.00137	CcSEcCtD
Nadolol—Cough—Gemcitabine—kidney cancer	0.000294	0.00136	CcSEcCtD
Nadolol—Constipation—Sunitinib—kidney cancer	0.000293	0.00136	CcSEcCtD
Nadolol—Pain—Sunitinib—kidney cancer	0.000293	0.00136	CcSEcCtD
Nadolol—Hypertension—Gemcitabine—kidney cancer	0.000291	0.00135	CcSEcCtD
Nadolol—Pruritus—Everolimus—kidney cancer	0.000291	0.00135	CcSEcCtD
Nadolol—Oedema—Vincristine—kidney cancer	0.00029	0.00135	CcSEcCtD
Nadolol—Conjunctivitis—Capecitabine—kidney cancer	0.000288	0.00134	CcSEcCtD
Nadolol—Chest pain—Gemcitabine—kidney cancer	0.000287	0.00133	CcSEcCtD
Nadolol—Alopecia—Paclitaxel—kidney cancer	0.000287	0.00133	CcSEcCtD
Nadolol—Asthenia—Erlotinib—kidney cancer	0.000284	0.00132	CcSEcCtD
Nadolol—Decreased appetite—Dactinomycin—kidney cancer	0.000282	0.00131	CcSEcCtD
Nadolol—Diarrhoea—Vinblastine—kidney cancer	0.000282	0.00131	CcSEcCtD
Nadolol—Body temperature increased—Sorafenib—kidney cancer	0.000282	0.00131	CcSEcCtD
Nadolol—Diarrhoea—Everolimus—kidney cancer	0.000281	0.0013	CcSEcCtD
Nadolol—Hyperhidrosis—Vincristine—kidney cancer	0.000281	0.0013	CcSEcCtD
Nadolol—Pruritus—Erlotinib—kidney cancer	0.00028	0.0013	CcSEcCtD
Nadolol—Fatigue—Dactinomycin—kidney cancer	0.00028	0.0013	CcSEcCtD
Nadolol—Flatulence—Paclitaxel—kidney cancer	0.000278	0.00129	CcSEcCtD
Nadolol—Pain—Dactinomycin—kidney cancer	0.000278	0.00129	CcSEcCtD
Nadolol—Agranulocytosis—Capecitabine—kidney cancer	0.000277	0.00128	CcSEcCtD
Nadolol—Anorexia—Vincristine—kidney cancer	0.000277	0.00128	CcSEcCtD
Nadolol—Oedema—Gemcitabine—kidney cancer	0.000275	0.00128	CcSEcCtD
Nadolol—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000274	0.00127	CcSEcCtD
Nadolol—Dizziness—Vinblastine—kidney cancer	0.000273	0.00126	CcSEcCtD
Nadolol—Dizziness—Everolimus—kidney cancer	0.000272	0.00126	CcSEcCtD
Nadolol—Body temperature increased—Sunitinib—kidney cancer	0.000271	0.00126	CcSEcCtD
Nadolol—Diarrhoea—Erlotinib—kidney cancer	0.000271	0.00126	CcSEcCtD
Nadolol—Hypotension—Vincristine—kidney cancer	0.000271	0.00126	CcSEcCtD
Nadolol—Bradycardia—Capecitabine—kidney cancer	0.000271	0.00126	CcSEcCtD
Nadolol—Vision blurred—Paclitaxel—kidney cancer	0.000266	0.00123	CcSEcCtD
Nadolol—Hyperhidrosis—Gemcitabine—kidney cancer	0.000266	0.00123	CcSEcCtD
Nadolol—Insomnia—Vincristine—kidney cancer	0.000263	0.00122	CcSEcCtD
Nadolol—Anorexia—Gemcitabine—kidney cancer	0.000262	0.00122	CcSEcCtD
Nadolol—Vomiting—Vinblastine—kidney cancer	0.000262	0.00122	CcSEcCtD
Nadolol—Dizziness—Erlotinib—kidney cancer	0.000262	0.00121	CcSEcCtD
Nadolol—Vomiting—Everolimus—kidney cancer	0.000261	0.00121	CcSEcCtD
Nadolol—Paraesthesia—Vincristine—kidney cancer	0.000261	0.00121	CcSEcCtD
Nadolol—Rash—Everolimus—kidney cancer	0.000259	0.0012	CcSEcCtD
Nadolol—Dermatitis—Everolimus—kidney cancer	0.000259	0.0012	CcSEcCtD
Nadolol—Hypotension—Gemcitabine—kidney cancer	0.000257	0.00119	CcSEcCtD
Nadolol—Body temperature increased—Dactinomycin—kidney cancer	0.000257	0.00119	CcSEcCtD
Nadolol—Visual impairment—Capecitabine—kidney cancer	0.000257	0.00119	CcSEcCtD
Nadolol—Asthenia—Sorafenib—kidney cancer	0.000256	0.00119	CcSEcCtD
Nadolol—Cardiac failure—Doxorubicin—kidney cancer	0.000254	0.00118	CcSEcCtD
Nadolol—Syncope—Paclitaxel—kidney cancer	0.000253	0.00117	CcSEcCtD
Nadolol—Lethargy—Doxorubicin—kidney cancer	0.000253	0.00117	CcSEcCtD
Nadolol—Decreased appetite—Vincristine—kidney cancer	0.000252	0.00117	CcSEcCtD
Nadolol—Pruritus—Sorafenib—kidney cancer	0.000252	0.00117	CcSEcCtD
Nadolol—Vomiting—Erlotinib—kidney cancer	0.000252	0.00117	CcSEcCtD
Nadolol—Fatigue—Vincristine—kidney cancer	0.00025	0.00116	CcSEcCtD
Nadolol—Rash—Erlotinib—kidney cancer	0.00025	0.00116	CcSEcCtD
Nadolol—Dermatitis—Erlotinib—kidney cancer	0.00025	0.00116	CcSEcCtD
Nadolol—Insomnia—Gemcitabine—kidney cancer	0.000249	0.00115	CcSEcCtD
Nadolol—Tinnitus—Capecitabine—kidney cancer	0.000248	0.00115	CcSEcCtD
Nadolol—Loss of consciousness—Paclitaxel—kidney cancer	0.000248	0.00115	CcSEcCtD
Nadolol—Pain—Vincristine—kidney cancer	0.000248	0.00115	CcSEcCtD
Nadolol—Constipation—Vincristine—kidney cancer	0.000248	0.00115	CcSEcCtD
Nadolol—Diplopia—Doxorubicin—kidney cancer	0.000248	0.00115	CcSEcCtD
Nadolol—Paraesthesia—Gemcitabine—kidney cancer	0.000247	0.00115	CcSEcCtD
Nadolol—Cough—Paclitaxel—kidney cancer	0.000247	0.00114	CcSEcCtD
Nadolol—Asthenia—Sunitinib—kidney cancer	0.000246	0.00114	CcSEcCtD
Nadolol—Dyspnoea—Gemcitabine—kidney cancer	0.000245	0.00114	CcSEcCtD
Nadolol—Nausea—Vinblastine—kidney cancer	0.000245	0.00114	CcSEcCtD
Nadolol—Affect lability—Doxorubicin—kidney cancer	0.000244	0.00113	CcSEcCtD
Nadolol—Nausea—Everolimus—kidney cancer	0.000244	0.00113	CcSEcCtD
Nadolol—Diarrhoea—Sorafenib—kidney cancer	0.000244	0.00113	CcSEcCtD
Nadolol—Hypertension—Paclitaxel—kidney cancer	0.000244	0.00113	CcSEcCtD
Nadolol—Pruritus—Sunitinib—kidney cancer	0.000243	0.00113	CcSEcCtD
Nadolol—Chest pain—Paclitaxel—kidney cancer	0.00024	0.00111	CcSEcCtD
Nadolol—Decreased appetite—Gemcitabine—kidney cancer	0.000239	0.00111	CcSEcCtD
Nadolol—Fatigue—Gemcitabine—kidney cancer	0.000237	0.0011	CcSEcCtD
Nadolol—Dizziness—Sorafenib—kidney cancer	0.000236	0.00109	CcSEcCtD
Nadolol—Constipation—Gemcitabine—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Pain—Gemcitabine—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Nausea—Erlotinib—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Alopecia—Capecitabine—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Dry mouth—Paclitaxel—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Mood swings—Doxorubicin—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Diarrhoea—Sunitinib—kidney cancer	0.000235	0.00109	CcSEcCtD
Nadolol—Asthenia—Dactinomycin—kidney cancer	0.000233	0.00108	CcSEcCtD
Nadolol—Oedema—Paclitaxel—kidney cancer	0.000231	0.00107	CcSEcCtD
Nadolol—Body temperature increased—Vincristine—kidney cancer	0.000229	0.00106	CcSEcCtD
Nadolol—Flatulence—Capecitabine—kidney cancer	0.000228	0.00106	CcSEcCtD
Nadolol—Dry skin—Doxorubicin—kidney cancer	0.000227	0.00105	CcSEcCtD
Nadolol—Dizziness—Sunitinib—kidney cancer	0.000227	0.00105	CcSEcCtD
Nadolol—Shock—Paclitaxel—kidney cancer	0.000227	0.00105	CcSEcCtD
Nadolol—Vomiting—Sorafenib—kidney cancer	0.000227	0.00105	CcSEcCtD
Nadolol—Rash—Sorafenib—kidney cancer	0.000225	0.00104	CcSEcCtD
Nadolol—Dermatitis—Sorafenib—kidney cancer	0.000225	0.00104	CcSEcCtD
Nadolol—Hyperhidrosis—Paclitaxel—kidney cancer	0.000223	0.00103	CcSEcCtD
Nadolol—Diarrhoea—Dactinomycin—kidney cancer	0.000222	0.00103	CcSEcCtD
Nadolol—Anorexia—Paclitaxel—kidney cancer	0.00022	0.00102	CcSEcCtD
Nadolol—Gastritis—Doxorubicin—kidney cancer	0.00022	0.00102	CcSEcCtD
Nadolol—Vision blurred—Capecitabine—kidney cancer	0.000218	0.00101	CcSEcCtD
Nadolol—Vomiting—Sunitinib—kidney cancer	0.000218	0.00101	CcSEcCtD
Nadolol—Body temperature increased—Gemcitabine—kidney cancer	0.000218	0.00101	CcSEcCtD
Nadolol—Rash—Sunitinib—kidney cancer	0.000216	0.001	CcSEcCtD
Nadolol—Dermatitis—Sunitinib—kidney cancer	0.000216	0.001	CcSEcCtD
Nadolol—Abdominal distension—Doxorubicin—kidney cancer	0.000216	0.001	CcSEcCtD
Nadolol—Hypotension—Paclitaxel—kidney cancer	0.000215	0.000998	CcSEcCtD
Nadolol—Nausea—Sorafenib—kidney cancer	0.000212	0.000982	CcSEcCtD
Nadolol—Insomnia—Paclitaxel—kidney cancer	0.000209	0.000966	CcSEcCtD
Nadolol—Asthenia—Vincristine—kidney cancer	0.000208	0.000965	CcSEcCtD
Nadolol—Syncope—Capecitabine—kidney cancer	0.000208	0.000963	CcSEcCtD
Nadolol—Paraesthesia—Paclitaxel—kidney cancer	0.000207	0.000959	CcSEcCtD
Nadolol—Vomiting—Dactinomycin—kidney cancer	0.000207	0.000957	CcSEcCtD
Nadolol—Dyspnoea—Paclitaxel—kidney cancer	0.000206	0.000953	CcSEcCtD
Nadolol—Rash—Dactinomycin—kidney cancer	0.000205	0.000949	CcSEcCtD
Nadolol—Nausea—Sunitinib—kidney cancer	0.000204	0.000945	CcSEcCtD
Nadolol—Loss of consciousness—Capecitabine—kidney cancer	0.000204	0.000944	CcSEcCtD
Nadolol—Dyspepsia—Paclitaxel—kidney cancer	0.000203	0.000941	CcSEcCtD
Nadolol—Cough—Capecitabine—kidney cancer	0.000202	0.000937	CcSEcCtD
Nadolol—Decreased appetite—Paclitaxel—kidney cancer	0.0002	0.000929	CcSEcCtD
Nadolol—Hypertension—Capecitabine—kidney cancer	0.0002	0.000928	CcSEcCtD
Nadolol—Fatigue—Paclitaxel—kidney cancer	0.000199	0.000921	CcSEcCtD
Nadolol—Diarrhoea—Vincristine—kidney cancer	0.000199	0.00092	CcSEcCtD
Nadolol—Asthenia—Gemcitabine—kidney cancer	0.000198	0.000916	CcSEcCtD
Nadolol—Chest pain—Capecitabine—kidney cancer	0.000197	0.000915	CcSEcCtD
Nadolol—Pain—Paclitaxel—kidney cancer	0.000197	0.000914	CcSEcCtD
Nadolol—Constipation—Paclitaxel—kidney cancer	0.000197	0.000914	CcSEcCtD
Nadolol—Weight increased—Doxorubicin—kidney cancer	0.000195	0.000905	CcSEcCtD
Nadolol—Pruritus—Gemcitabine—kidney cancer	0.000195	0.000903	CcSEcCtD
Nadolol—Dry mouth—Capecitabine—kidney cancer	0.000193	0.000895	CcSEcCtD
Nadolol—Nausea—Dactinomycin—kidney cancer	0.000193	0.000894	CcSEcCtD
Nadolol—Dizziness—Vincristine—kidney cancer	0.000192	0.00089	CcSEcCtD
Nadolol—Oedema—Capecitabine—kidney cancer	0.000189	0.000877	CcSEcCtD
Nadolol—Diarrhoea—Gemcitabine—kidney cancer	0.000188	0.000873	CcSEcCtD
Nadolol—Shock—Capecitabine—kidney cancer	0.000186	0.000863	CcSEcCtD
Nadolol—Conjunctivitis—Doxorubicin—kidney cancer	0.000186	0.000861	CcSEcCtD
Nadolol—Vomiting—Vincristine—kidney cancer	0.000185	0.000855	CcSEcCtD
Nadolol—Sweating—Doxorubicin—kidney cancer	0.000183	0.00085	CcSEcCtD
Nadolol—Rash—Vincristine—kidney cancer	0.000183	0.000848	CcSEcCtD
Nadolol—Hyperhidrosis—Capecitabine—kidney cancer	0.000183	0.000848	CcSEcCtD
Nadolol—Dermatitis—Vincristine—kidney cancer	0.000183	0.000847	CcSEcCtD
Nadolol—Body temperature increased—Paclitaxel—kidney cancer	0.000182	0.000845	CcSEcCtD
Nadolol—Anorexia—Capecitabine—kidney cancer	0.00018	0.000836	CcSEcCtD
Nadolol—Agranulocytosis—Doxorubicin—kidney cancer	0.000178	0.000827	CcSEcCtD
Nadolol—Hypotension—Capecitabine—kidney cancer	0.000177	0.000819	CcSEcCtD
Nadolol—Vomiting—Gemcitabine—kidney cancer	0.000175	0.000811	CcSEcCtD
Nadolol—Bradycardia—Doxorubicin—kidney cancer	0.000175	0.00081	CcSEcCtD
Nadolol—Rash—Gemcitabine—kidney cancer	0.000174	0.000805	CcSEcCtD
Nadolol—Dermatitis—Gemcitabine—kidney cancer	0.000173	0.000804	CcSEcCtD
Nadolol—Nausea—Vincristine—kidney cancer	0.000172	0.000799	CcSEcCtD
Nadolol—Insomnia—Capecitabine—kidney cancer	0.000171	0.000793	CcSEcCtD
Nadolol—Paraesthesia—Capecitabine—kidney cancer	0.00017	0.000787	CcSEcCtD
Nadolol—Dyspnoea—Capecitabine—kidney cancer	0.000169	0.000782	CcSEcCtD
Nadolol—Dyspepsia—Capecitabine—kidney cancer	0.000167	0.000772	CcSEcCtD
Nadolol—Visual impairment—Doxorubicin—kidney cancer	0.000165	0.000767	CcSEcCtD
Nadolol—Asthenia—Paclitaxel—kidney cancer	0.000165	0.000767	CcSEcCtD
Nadolol—Decreased appetite—Capecitabine—kidney cancer	0.000164	0.000762	CcSEcCtD
Nadolol—Nausea—Gemcitabine—kidney cancer	0.000164	0.000758	CcSEcCtD
Nadolol—Fatigue—Capecitabine—kidney cancer	0.000163	0.000756	CcSEcCtD
Nadolol—Pruritus—Paclitaxel—kidney cancer	0.000163	0.000756	CcSEcCtD
Nadolol—Constipation—Capecitabine—kidney cancer	0.000162	0.00075	CcSEcCtD
Nadolol—Pain—Capecitabine—kidney cancer	0.000162	0.00075	CcSEcCtD
Nadolol—Tinnitus—Doxorubicin—kidney cancer	0.00016	0.000742	CcSEcCtD
Nadolol—Diarrhoea—Paclitaxel—kidney cancer	0.000158	0.000731	CcSEcCtD
Nadolol—Dizziness—Paclitaxel—kidney cancer	0.000152	0.000707	CcSEcCtD
Nadolol—Alopecia—Doxorubicin—kidney cancer	0.000152	0.000703	CcSEcCtD
Nadolol—Body temperature increased—Capecitabine—kidney cancer	0.00015	0.000693	CcSEcCtD
Nadolol—Flatulence—Doxorubicin—kidney cancer	0.000147	0.000682	CcSEcCtD
Nadolol—Vomiting—Paclitaxel—kidney cancer	0.000147	0.000679	CcSEcCtD
Nadolol—Rash—Paclitaxel—kidney cancer	0.000145	0.000674	CcSEcCtD
Nadolol—Dermatitis—Paclitaxel—kidney cancer	0.000145	0.000673	CcSEcCtD
Nadolol—Vision blurred—Doxorubicin—kidney cancer	0.000141	0.000653	CcSEcCtD
Nadolol—Nausea—Paclitaxel—kidney cancer	0.000137	0.000635	CcSEcCtD
Nadolol—Asthenia—Capecitabine—kidney cancer	0.000136	0.000629	CcSEcCtD
Nadolol—Syncope—Doxorubicin—kidney cancer	0.000134	0.000621	CcSEcCtD
Nadolol—Pruritus—Capecitabine—kidney cancer	0.000134	0.00062	CcSEcCtD
Nadolol—Loss of consciousness—Doxorubicin—kidney cancer	0.000131	0.000609	CcSEcCtD
Nadolol—Cough—Doxorubicin—kidney cancer	0.00013	0.000604	CcSEcCtD
Nadolol—Diarrhoea—Capecitabine—kidney cancer	0.000129	0.0006	CcSEcCtD
Nadolol—Hypertension—Doxorubicin—kidney cancer	0.000129	0.000598	CcSEcCtD
Nadolol—Chest pain—Doxorubicin—kidney cancer	0.000127	0.00059	CcSEcCtD
Nadolol—Dizziness—Capecitabine—kidney cancer	0.000125	0.00058	CcSEcCtD
Nadolol—Dry mouth—Doxorubicin—kidney cancer	0.000124	0.000577	CcSEcCtD
Nadolol—Oedema—Doxorubicin—kidney cancer	0.000122	0.000565	CcSEcCtD
Nadolol—Vomiting—Capecitabine—kidney cancer	0.00012	0.000557	CcSEcCtD
Nadolol—Shock—Doxorubicin—kidney cancer	0.00012	0.000556	CcSEcCtD
Nadolol—Rash—Capecitabine—kidney cancer	0.000119	0.000553	CcSEcCtD
Nadolol—Dermatitis—Capecitabine—kidney cancer	0.000119	0.000552	CcSEcCtD
Nadolol—Hyperhidrosis—Doxorubicin—kidney cancer	0.000118	0.000546	CcSEcCtD
Nadolol—Anorexia—Doxorubicin—kidney cancer	0.000116	0.000539	CcSEcCtD
Nadolol—Hypotension—Doxorubicin—kidney cancer	0.000114	0.000528	CcSEcCtD
Nadolol—Nausea—Capecitabine—kidney cancer	0.000112	0.000521	CcSEcCtD
Nadolol—Insomnia—Doxorubicin—kidney cancer	0.00011	0.000511	CcSEcCtD
Nadolol—Paraesthesia—Doxorubicin—kidney cancer	0.00011	0.000508	CcSEcCtD
Nadolol—Dyspnoea—Doxorubicin—kidney cancer	0.000109	0.000504	CcSEcCtD
Nadolol—Dyspepsia—Doxorubicin—kidney cancer	0.000107	0.000498	CcSEcCtD
Nadolol—Decreased appetite—Doxorubicin—kidney cancer	0.000106	0.000491	CcSEcCtD
Nadolol—Fatigue—Doxorubicin—kidney cancer	0.000105	0.000487	CcSEcCtD
Nadolol—Pain—Doxorubicin—kidney cancer	0.000104	0.000483	CcSEcCtD
Nadolol—Constipation—Doxorubicin—kidney cancer	0.000104	0.000483	CcSEcCtD
Nadolol—Body temperature increased—Doxorubicin—kidney cancer	9.64e-05	0.000447	CcSEcCtD
Nadolol—Asthenia—Doxorubicin—kidney cancer	8.75e-05	0.000406	CcSEcCtD
Nadolol—Pruritus—Doxorubicin—kidney cancer	8.63e-05	0.0004	CcSEcCtD
Nadolol—Diarrhoea—Doxorubicin—kidney cancer	8.34e-05	0.000387	CcSEcCtD
Nadolol—Dizziness—Doxorubicin—kidney cancer	8.06e-05	0.000374	CcSEcCtD
Nadolol—Vomiting—Doxorubicin—kidney cancer	7.75e-05	0.000359	CcSEcCtD
Nadolol—Rash—Doxorubicin—kidney cancer	7.69e-05	0.000356	CcSEcCtD
Nadolol—Dermatitis—Doxorubicin—kidney cancer	7.68e-05	0.000356	CcSEcCtD
Nadolol—Nausea—Doxorubicin—kidney cancer	7.24e-05	0.000336	CcSEcCtD
